See All Resources

Home > Resources > Member Publication > Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin

Go to Resource
Share:

Link is copied!

Get Certified

See All Certifications
A white doctor and a black doctor discuss the test results

Cardio-Oncology Knowledge

Go To Certification
A map of the world
Chapters

North America

Europe

Asia + Oceania

South America

Africa